Such discrepancy in the described role of IL-38 in the development of cancer may likely relate to regulatory regulation of terminal differentiation of TAMs in the tumour microenvironments (55), dependant on the individual local and/or systemic responses. The gene discussed is IL1F10; the disease is cancer.